---
created: 2025-04-13
updated: 2025-04-13T10:53
id: H1gK97O2bj
specialty: gastro
specialty_id: 155
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/firstaid::09-gastrointestinal::04-pathology::46-biliary-tract-disease::cholestatic-drugs::obeticholic-acid
  - "source/ak-step1-v11:": 
  - theme/firstaid::09-gastrointestinal::05-pharm::16-cholestatic-drugs
  - "source/ak-step1-v11:": 
  - theme/firstaid::09-gastrointestinal::05-pharm::16-cholestatic-drugs::obeticholic-acid
  - "source/ak-step1-v11:": 
  - source/ome-banner
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::05-gi-&-endocrine::fa-gi
  - source/ak-step1-v11::^other::^expn
  - source/ak-step1-v11::^other::^highyield::3-highyield-temporary
  - source/ak-step1-v11::^systems::gi::pharm"
type: flashcard
---

# Question
Pharmacology: Cholestatic Drugs   Patients using Obeticholic Acid commonly experience **itching**, but incorrect dosing can lead to serious **liver injury**

---

# Answer
Therefore, extremely important to watch LFTs